Structure

Physi-Chem Properties

Molecular Weight:  614.18
Volume:  569.431
LogP:  0.421
LogD:  0.182
LogS:  -2.356
# Rotatable Bonds:  15
TPSA:  234.04
# H-Bond Aceptor:  16
# H-Bond Donor:  5
# Rings:  3
# Heavy Atoms:  16

MedChem Properties

QED Drug-Likeness Score:  0.106
Synthetic Accessibility Score:  4.782
Fsp3:  0.556
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.275
MDCK Permeability:  0.00010844830831047148
Pgp-inhibitor:  0.01
Pgp-substrate:  0.995
Human Intestinal Absorption (HIA):  0.995
20% Bioavailability (F20%):  0.997
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.173
Plasma Protein Binding (PPB):  22.32915496826172%
Volume Distribution (VD):  0.409
Pgp-substrate:  50.25643539428711%

ADMET: Metabolism

CYP1A2-inhibitor:  0.014
CYP1A2-substrate:  0.02
CYP2C19-inhibitor:  0.019
CYP2C19-substrate:  0.057
CYP2C9-inhibitor:  0.004
CYP2C9-substrate:  0.033
CYP2D6-inhibitor:  0.031
CYP2D6-substrate:  0.069
CYP3A4-inhibitor:  0.14
CYP3A4-substrate:  0.104

ADMET: Excretion

Clearance (CL):  1.759
Half-life (T1/2):  0.947

ADMET: Toxicity

hERG Blockers:  0.401
Human Hepatotoxicity (H-HT):  0.161
Drug-inuced Liver Injury (DILI):  0.776
AMES Toxicity:  0.177
Rat Oral Acute Toxicity:  0.024
Maximum Recommended Daily Dose:  0.002
Skin Sensitization:  0.835
Carcinogencity:  0.127
Eye Corrosion:  0.003
Eye Irritation:  0.018
Respiratory Toxicity:  0.009

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC45224

Natural Product ID:  NPC45224
Common Name*:   3-P-O-Coumaroyl-1,2',6'-O-Triacetyl Sucrose
IUPAC Name:   [(2S,3S,4R,5R)-2-[(2R,3R,4S,5S,6R)-3-acetyloxy-6-(acetyloxymethyl)-4,5-dihydroxyoxan-2-yl]oxy-2-(acetyloxymethyl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate
Synonyms:  
Standard InCHIKey:  IUWNEFXWBDZQHK-PZHMIARSSA-N
Standard InCHI:  InChI=1S/C27H34O16/c1-13(29)37-11-19-21(34)23(36)24(39-15(3)31)26(40-19)43-27(12-38-14(2)30)25(22(35)18(10-28)42-27)41-20(33)9-6-16-4-7-17(32)8-5-16/h4-9,18-19,21-26,28,32,34-36H,10-12H2,1-3H3/b9-6+/t18-,19-,21-,22-,23+,24-,25+,26-,27+/m1/s1
SMILES:  CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@]1(COC(=O)C)[C@H]([C@@H]([C@@H](CO)O1)O)OC(=O)/C=C/c1ccc(cc1)O)OC(=O)C)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3262775
PubChem CID:   14841107
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000476] Cinnamic acids and derivatives
        • [CHEMONTID:0001391] Hydroxycinnamic acids and derivatives
          • [CHEMONTID:0003002] Hydroxycinnamic acid esters
            • [CHEMONTID:0000465] Coumaric acid esters

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO27241 Prunus tomentosa Species Rosaceae Eukaryota n.a. seed n.a. PMID[18449498]
NPO27241 Prunus tomentosa Species Rosaceae Eukaryota leaves n.a. n.a. PMID[24767839]
NPO27241 Prunus tomentosa Species Rosaceae Eukaryota n.a. n.a. Database[FooDB]
NPO27241 Prunus tomentosa Species Rosaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO27241 Prunus tomentosa Species Rosaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO27241 Prunus tomentosa Species Rosaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens IC50 = 3440.0 nM PMID[455835]
NPT81 Cell Line A549 Homo sapiens IC50 = 3200.0 nM PMID[455835]
NPT165 Cell Line HeLa Homo sapiens IC50 = 2490.0 nM PMID[455835]
NPT139 Cell Line HT-29 Homo sapiens IC50 = 3960.0 nM PMID[455835]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC45224 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC35288
1.0 High Similarity NPC173150
1.0 High Similarity NPC471882
1.0 High Similarity NPC156692
1.0 High Similarity NPC471881
0.9752 High Similarity NPC61181
0.9672 High Similarity NPC103533
0.9593 High Similarity NPC225307
0.9583 High Similarity NPC52097
0.9512 High Similarity NPC106677
0.95 High Similarity NPC11724
0.9449 High Similarity NPC471883
0.9431 High Similarity NPC471157
0.9417 High Similarity NPC476872
0.937 High Similarity NPC28637
0.9365 High Similarity NPC281798
0.9365 High Similarity NPC478255
0.935 High Similarity NPC83218
0.935 High Similarity NPC126991
0.9274 High Similarity NPC252114
0.9219 High Similarity NPC254398
0.9213 High Similarity NPC219677
0.9213 High Similarity NPC138777
0.9213 High Similarity NPC46137
0.9213 High Similarity NPC235294
0.9213 High Similarity NPC246869
0.9213 High Similarity NPC225384
0.92 High Similarity NPC288416
0.9141 High Similarity NPC473924
0.9077 High Similarity NPC263829
0.9062 High Similarity NPC254819
0.9055 High Similarity NPC253595
0.9055 High Similarity NPC477294
0.9055 High Similarity NPC477293
0.9055 High Similarity NPC229784
0.9016 High Similarity NPC282409
0.9016 High Similarity NPC469702
0.8992 High Similarity NPC473285
0.8976 High Similarity NPC232880
0.8943 High Similarity NPC469548
0.8943 High Similarity NPC476445
0.8943 High Similarity NPC476448
0.8939 High Similarity NPC476376
0.8898 High Similarity NPC476873
0.8872 High Similarity NPC328273
0.8872 High Similarity NPC171134
0.8872 High Similarity NPC220942
0.8872 High Similarity NPC226005
0.8872 High Similarity NPC321184
0.8872 High Similarity NPC321638
0.8864 High Similarity NPC470572
0.8855 High Similarity NPC169398
0.8833 High Similarity NPC313193
0.8824 High Similarity NPC196063
0.8824 High Similarity NPC300894
0.8824 High Similarity NPC296954
0.8824 High Similarity NPC141455
0.8797 High Similarity NPC469364
0.8797 High Similarity NPC65262
0.8797 High Similarity NPC101686
0.876 High Similarity NPC295970
0.8759 High Similarity NPC262182
0.8759 High Similarity NPC287615
0.8759 High Similarity NPC216819
0.8759 High Similarity NPC83743
0.875 High Similarity NPC293154
0.875 High Similarity NPC105005
0.875 High Similarity NPC40305
0.8741 High Similarity NPC476385
0.8741 High Similarity NPC134405
0.8741 High Similarity NPC47471
0.8741 High Similarity NPC476377
0.8731 High Similarity NPC220936
0.8731 High Similarity NPC197316
0.8731 High Similarity NPC31745
0.8731 High Similarity NPC64141
0.8731 High Similarity NPC476383
0.8731 High Similarity NPC472350
0.8731 High Similarity NPC205195
0.8731 High Similarity NPC68092
0.8731 High Similarity NPC89105
0.8731 High Similarity NPC81515
0.8731 High Similarity NPC49597
0.8722 High Similarity NPC157554
0.8712 High Similarity NPC287597
0.8712 High Similarity NPC886
0.8712 High Similarity NPC34293
0.8696 High Similarity NPC229505
0.8689 High Similarity NPC148055
0.8689 High Similarity NPC175771
0.8686 High Similarity NPC297342
0.8686 High Similarity NPC110063
0.8667 High Similarity NPC475530
0.8667 High Similarity NPC473799
0.8657 High Similarity NPC260425
0.8651 High Similarity NPC471067
0.8647 High Similarity NPC476870
0.8636 High Similarity NPC114116
0.8615 High Similarity NPC469549
0.8613 High Similarity NPC264632
0.8613 High Similarity NPC476378
0.8613 High Similarity NPC476375
0.8613 High Similarity NPC476380
0.8613 High Similarity NPC247032
0.8613 High Similarity NPC112
0.8613 High Similarity NPC298257
0.8613 High Similarity NPC205864
0.8613 High Similarity NPC476397
0.8613 High Similarity NPC175214
0.8613 High Similarity NPC478250
0.8613 High Similarity NPC96795
0.8613 High Similarity NPC76406
0.8613 High Similarity NPC476384
0.8613 High Similarity NPC476381
0.8613 High Similarity NPC119537
0.8613 High Similarity NPC269141
0.8593 High Similarity NPC100389
0.8583 High Similarity NPC232454
0.8583 High Similarity NPC178449
0.8583 High Similarity NPC470907
0.8582 High Similarity NPC472132
0.8582 High Similarity NPC166180
0.8582 High Similarity NPC37468
0.8582 High Similarity NPC471345
0.8571 High Similarity NPC80732
0.8571 High Similarity NPC199311
0.8571 High Similarity NPC201148
0.8571 High Similarity NPC215095
0.8571 High Similarity NPC55608
0.8571 High Similarity NPC192763
0.8571 High Similarity NPC261122
0.8571 High Similarity NPC28651
0.8571 High Similarity NPC300262
0.8571 High Similarity NPC3460
0.8571 High Similarity NPC210611
0.8551 High Similarity NPC64195
0.8551 High Similarity NPC251062
0.8551 High Similarity NPC296659
0.8551 High Similarity NPC202391
0.8551 High Similarity NPC63304
0.8551 High Similarity NPC184464
0.854 High Similarity NPC222433
0.854 High Similarity NPC265648
0.8538 High Similarity NPC146540
0.8525 High Similarity NPC157338
0.8519 High Similarity NPC78363
0.8511 High Similarity NPC283839
0.8511 High Similarity NPC90896
0.8507 High Similarity NPC185778
0.8492 Intermediate Similarity NPC201402
0.8492 Intermediate Similarity NPC469703
0.8492 Intermediate Similarity NPC160854
0.8492 Intermediate Similarity NPC229600
0.8492 Intermediate Similarity NPC469704
0.8478 Intermediate Similarity NPC88754
0.8478 Intermediate Similarity NPC152796
0.8478 Intermediate Similarity NPC237872
0.8478 Intermediate Similarity NPC475213
0.8478 Intermediate Similarity NPC263397
0.8478 Intermediate Similarity NPC204644
0.8478 Intermediate Similarity NPC302286
0.8478 Intermediate Similarity NPC186296
0.8478 Intermediate Similarity NPC116104
0.8467 Intermediate Similarity NPC137501
0.8467 Intermediate Similarity NPC7518
0.8467 Intermediate Similarity NPC159387
0.8467 Intermediate Similarity NPC46644
0.8467 Intermediate Similarity NPC154262
0.8462 Intermediate Similarity NPC469687
0.8451 Intermediate Similarity NPC188393
0.8451 Intermediate Similarity NPC470934
0.8444 Intermediate Similarity NPC186418
0.8429 Intermediate Similarity NPC320734
0.8429 Intermediate Similarity NPC37838
0.8429 Intermediate Similarity NPC473147
0.8429 Intermediate Similarity NPC476865
0.8425 Intermediate Similarity NPC469686
0.8417 Intermediate Similarity NPC194938
0.8417 Intermediate Similarity NPC476867
0.8406 Intermediate Similarity NPC296643
0.8406 Intermediate Similarity NPC157816
0.8406 Intermediate Similarity NPC140502
0.8394 Intermediate Similarity NPC202700
0.8392 Intermediate Similarity NPC85192
0.8392 Intermediate Similarity NPC125823
0.8392 Intermediate Similarity NPC7145
0.8392 Intermediate Similarity NPC143480
0.8372 Intermediate Similarity NPC287429
0.8357 Intermediate Similarity NPC476382
0.8357 Intermediate Similarity NPC34927
0.8357 Intermediate Similarity NPC252292
0.8357 Intermediate Similarity NPC100998
0.8357 Intermediate Similarity NPC476864
0.8357 Intermediate Similarity NPC476868
0.8357 Intermediate Similarity NPC34587
0.8357 Intermediate Similarity NPC476869
0.8357 Intermediate Similarity NPC476866
0.8347 Intermediate Similarity NPC43584
0.8345 Intermediate Similarity NPC478239
0.8333 Intermediate Similarity NPC289967

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC45224 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8731 High Similarity NPD7266 Discontinued
0.7863 Intermediate Similarity NPD1091 Approved
0.7755 Intermediate Similarity NPD1653 Approved
0.7698 Intermediate Similarity NPD969 Suspended
0.752 Intermediate Similarity NPD1358 Approved
0.7466 Intermediate Similarity NPD6190 Approved
0.7424 Intermediate Similarity NPD9545 Approved
0.7302 Intermediate Similarity NPD3134 Approved
0.7273 Intermediate Similarity NPD8455 Phase 2
0.7244 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD7685 Pre-registration
0.7239 Intermediate Similarity NPD1357 Approved
0.7222 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD1652 Phase 2
0.7185 Intermediate Similarity NPD5125 Phase 3
0.7185 Intermediate Similarity NPD5126 Approved
0.7162 Intermediate Similarity NPD4628 Phase 3
0.7134 Intermediate Similarity NPD6559 Discontinued
0.7133 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD7097 Phase 1
0.7099 Intermediate Similarity NPD7843 Approved
0.7099 Intermediate Similarity NPD7228 Approved
0.7083 Intermediate Similarity NPD230 Phase 1
0.708 Intermediate Similarity NPD422 Phase 1
0.708 Intermediate Similarity NPD3705 Approved
0.7067 Intermediate Similarity NPD5058 Phase 3
0.7042 Intermediate Similarity NPD3027 Phase 3
0.7012 Intermediate Similarity NPD7472 Approved
0.6994 Remote Similarity NPD3818 Discontinued
0.6993 Remote Similarity NPD3764 Approved
0.6987 Remote Similarity NPD37 Approved
0.6981 Remote Similarity NPD6234 Discontinued
0.6978 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6966 Remote Similarity NPD5124 Phase 1
0.6966 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6966 Remote Similarity NPD4340 Discontinued
0.6962 Remote Similarity NPD4965 Approved
0.6962 Remote Similarity NPD4967 Phase 2
0.6962 Remote Similarity NPD4966 Approved
0.6951 Remote Similarity NPD7054 Approved
0.6951 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6944 Remote Similarity NPD6233 Phase 2
0.694 Remote Similarity NPD7157 Approved
0.6928 Remote Similarity NPD7251 Discontinued
0.6923 Remote Similarity NPD2684 Approved
0.6918 Remote Similarity NPD7075 Discontinued
0.6918 Remote Similarity NPD6653 Approved
0.6909 Remote Similarity NPD7074 Phase 3
0.6889 Remote Similarity NPD694 Clinical (unspecified phase)
0.6886 Remote Similarity NPD7808 Phase 3
0.6875 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6867 Remote Similarity NPD6797 Phase 2
0.6864 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6859 Remote Similarity NPD4380 Phase 2
0.6849 Remote Similarity NPD6355 Discontinued
0.6846 Remote Similarity NPD290 Approved
0.6845 Remote Similarity NPD8313 Approved
0.6845 Remote Similarity NPD8312 Approved
0.6826 Remote Similarity NPD7240 Approved
0.6821 Remote Similarity NPD1878 Clinical (unspecified phase)
0.68 Remote Similarity NPD2424 Discontinued
0.6786 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6781 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6781 Remote Similarity NPD4060 Phase 1
0.6781 Remote Similarity NPD1613 Approved
0.6777 Remote Similarity NPD689 Discontinued
0.6774 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6774 Remote Similarity NPD2933 Approved
0.6774 Remote Similarity NPD2934 Approved
0.6765 Remote Similarity NPD9493 Approved
0.6763 Remote Similarity NPD3496 Discontinued
0.6759 Remote Similarity NPD6798 Discontinued
0.6755 Remote Similarity NPD6674 Discontinued
0.675 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6733 Remote Similarity NPD5763 Approved
0.6733 Remote Similarity NPD5762 Approved
0.673 Remote Similarity NPD7096 Clinical (unspecified phase)
0.672 Remote Similarity NPD2859 Approved
0.672 Remote Similarity NPD2860 Approved
0.6718 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6713 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6713 Remote Similarity NPD5647 Approved
0.6712 Remote Similarity NPD4062 Phase 3
0.6711 Remote Similarity NPD8166 Discontinued
0.6711 Remote Similarity NPD7033 Discontinued
0.6711 Remote Similarity NPD5588 Approved
0.6688 Remote Similarity NPD6799 Approved
0.6687 Remote Similarity NPD7199 Phase 2
0.6667 Remote Similarity NPD5403 Approved
0.6667 Remote Similarity NPD6647 Phase 2
0.6667 Remote Similarity NPD5736 Approved
0.6667 Remote Similarity NPD6801 Discontinued
0.6667 Remote Similarity NPD2861 Phase 2
0.6667 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6645 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6645 Remote Similarity NPD3536 Discontinued
0.6645 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6644 Remote Similarity NPD4538 Approved
0.6644 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6644 Remote Similarity NPD4536 Approved
0.6643 Remote Similarity NPD6362 Approved
0.6643 Remote Similarity NPD3094 Phase 2
0.6623 Remote Similarity NPD6002 Phase 3
0.6623 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6623 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6623 Remote Similarity NPD6005 Phase 3
0.6623 Remote Similarity NPD6004 Phase 3
0.6621 Remote Similarity NPD4908 Phase 1
0.6603 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6594 Remote Similarity NPD5536 Phase 2
0.6593 Remote Similarity NPD5535 Approved
0.6589 Remote Similarity NPD846 Approved
0.6589 Remote Similarity NPD940 Approved
0.6583 Remote Similarity NPD111 Approved
0.6582 Remote Similarity NPD7458 Discontinued
0.6575 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6575 Remote Similarity NPD7095 Approved
0.6573 Remote Similarity NPD3225 Approved
0.6573 Remote Similarity NPD8651 Approved
0.6571 Remote Similarity NPD4626 Approved
0.6562 Remote Similarity NPD3020 Approved
0.6556 Remote Similarity NPD2935 Discontinued
0.6547 Remote Similarity NPD1548 Phase 1
0.6538 Remote Similarity NPD5401 Approved
0.6531 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6525 Remote Similarity NPD3847 Discontinued
0.6522 Remote Similarity NPD2977 Approved
0.6522 Remote Similarity NPD2978 Approved
0.6519 Remote Similarity NPD228 Approved
0.6515 Remote Similarity NPD968 Approved
0.6512 Remote Similarity NPD1242 Phase 1
0.651 Remote Similarity NPD1933 Approved
0.6507 Remote Similarity NPD6832 Phase 2
0.6507 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6506 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6503 Remote Similarity NPD3685 Discontinued
0.65 Remote Similarity NPD7411 Suspended
0.65 Remote Similarity NPD5691 Approved
0.6494 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6493 Remote Similarity NPD3022 Approved
0.6493 Remote Similarity NPD3021 Approved
0.6493 Remote Similarity NPD2067 Discontinued
0.649 Remote Similarity NPD5960 Phase 3
0.6486 Remote Similarity NPD6663 Approved
0.6485 Remote Similarity NPD8127 Discontinued
0.6481 Remote Similarity NPD5402 Approved
0.6479 Remote Similarity NPD1535 Discovery
0.6479 Remote Similarity NPD1610 Phase 2
0.6479 Remote Similarity NPD3092 Approved
0.6478 Remote Similarity NPD3455 Phase 2
0.6475 Remote Similarity NPD1282 Approved
0.6471 Remote Similarity NPD1549 Phase 2
0.6471 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6467 Remote Similarity NPD2492 Phase 1
0.6463 Remote Similarity NPD3179 Approved
0.6463 Remote Similarity NPD3180 Approved
0.646 Remote Similarity NPD1934 Approved
0.6454 Remote Similarity NPD5238 Clinical (unspecified phase)
0.6454 Remote Similarity NPD1778 Approved
0.6449 Remote Similarity NPD4198 Discontinued
0.6449 Remote Similarity NPD6671 Approved
0.6447 Remote Similarity NPD1551 Phase 2
0.6443 Remote Similarity NPD4140 Approved
0.6442 Remote Similarity NPD3882 Suspended
0.6439 Remote Similarity NPD5048 Discontinued
0.6439 Remote Similarity NPD9697 Approved
0.6438 Remote Similarity NPD6599 Discontinued
0.6438 Remote Similarity NPD9494 Approved
0.6438 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6434 Remote Similarity NPD9717 Approved
0.6434 Remote Similarity NPD9269 Phase 2
0.6434 Remote Similarity NPD1481 Phase 2
0.6429 Remote Similarity NPD1894 Discontinued
0.6429 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6423 Remote Similarity NPD1241 Discontinued
0.642 Remote Similarity NPD7819 Suspended
0.642 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6419 Remote Similarity NPD1048 Approved
0.6415 Remote Similarity NPD3686 Approved
0.6415 Remote Similarity NPD3687 Approved
0.6414 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6414 Remote Similarity NPD1203 Approved
0.6414 Remote Similarity NPD2797 Approved
0.6405 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6405 Remote Similarity NPD7978 Discontinued
0.6405 Remote Similarity NPD1550 Clinical (unspecified phase)
0.64 Remote Similarity NPD6841 Approved
0.64 Remote Similarity NPD6843 Phase 3
0.64 Remote Similarity NPD6842 Approved
0.6398 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6389 Remote Similarity NPD2983 Phase 2
0.6389 Remote Similarity NPD2982 Phase 2
0.6387 Remote Similarity NPD3750 Approved
0.638 Remote Similarity NPD3817 Phase 2
0.6378 Remote Similarity NPD1432 Clinical (unspecified phase)
0.6377 Remote Similarity NPD2629 Approved
0.6377 Remote Similarity NPD690 Clinical (unspecified phase)
0.637 Remote Similarity NPD9380 Clinical (unspecified phase)
0.6369 Remote Similarity NPD6168 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data